| NOVEN
TO ANNOUNCE 2002 FINANCIAL RESULTS ON MARCH 3
|
|
Public
Invited to Listen to Earnings Conference Call Via Internet
Miami, FL, February
25, 2003 -- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN), a leading developer
of advanced transdermal drug delivery technologies and prescription
transdermal products, today announced its 2002 fourth quarter and year
end earnings release date.
On March 3, before the market opens, Noven is scheduled to issue a
press release announcing its financial results for the quarter and
year ended December 31, 2002. Beginning at 10:00 a.m. Eastern Time
the same day, a telephone conference among management and analysts
will be broadcast live via the Internet at www.noven.com, and a rebroadcast
will be accessible at the same site. A taped replay of the call will
be available by telephone beginning the morning of March 3 at 11:00
a.m. through noon on March 6 by calling 877-660-6853 (from within the
U.S.) or 201-612-7415 (from outside the U.S.) and entering (the conference
ID# 58491 and the access code 1628.)
Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a
leading developer of advanced transdermal drug delivery technologies
and prescription transdermal products. For additional information on
Noven, visit www.noven.com.
Contact:
Stefaney Caro
Corporate Affairs
Noven Pharmaceuticals, Inc.
(305) 253-1916
Copyright © 2003 Noven
Pharmaceuticals, Inc. All rights reserved.
|